Use of oral diabetes medications and the risk of incident dementia in US veterans aged ≥60 years with type 2 diabetes

INTRODUCTION: Studies have reported that antidiabetic medications (ADMs) were associated with lower risk of dementia, but current findings are inconsistent. This study compared the risk of dementia onset in patients with type 2 diabetes (T2D) treated with sulfonylurea (SU) or thiazolidinedione (TZD)...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Xin, Brinton, Roberta Diaz, Chen, Zhao, Farland, Leslie V, Klimentidis, Yann, Migrino, Raymond, Reaven, Peter, Rodgers, Kathleen, Zhou, Jin J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Cardiovascular and Metabolic Risk
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9472121/
https://www.ncbi.nlm.nih.gov/pubmed/36220195
http://dx.doi.org/10.1136/bmjdrc-2022-002894

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9472121/
https://www.ncbi.nlm.nih.gov/pubmed/36220195
http://dx.doi.org/10.1136/bmjdrc-2022-002894

Ejemplares similares